Chemical formula: C₅₅H₇₅N₁₇O₁₃ Molecular mass: 1,182.29 g/mol PubChem compound: 36523
Gonadorelin interacts in the following cases:
Gonadorelin should not be administered to pregnant women.
Gonadorelin should not be administered to nursing mothers.
Gonadorelin has no or negligible influence on the ability to drive and operate machines.
The following adverse drug reactions have been identified or suspected in clinical trials and through post-marketing use. Adverse reactions listed below are classified according to frequency and System Organ Class (SOC).
Frequency categories are defined according to the following convention:
Very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000), very rare (<1/10,000), not known (cannot be estimated from the available data).
Rare: tachycardia
Rare: nausea, abdominal discomfort
Rare: induration at injection site
Rare: hypersensitivity reactions
Frequency unknown: sepsis
Rare: antibody test – positive for antibody formation
Uncommon: pain
Rare: headache, dizziness
Frequency unknown: menorrhagia
Rare: bronchospasm
Uncommon: swelling, pruritis
Rare: urticaria, erythema, erythema of eyelid
Frequency unknown: rash
Rare: flushing
Frequency unknown: thrombophlebitis
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
